These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31005411)

  • 1. Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome.
    Hollister EB; Oezguen N; Chumpitazi BP; Luna RA; Weidler EM; Rubio-Gonzales M; Dahdouli M; Cope JL; Mistretta TA; Raza S; Metcalf GA; Muzny DM; Gibbs RA; Petrosino JF; Heitkemper M; Savidge TC; Shulman RJ; Versalovic J
    J Mol Diagn; 2019 May; 21(3):449-461. PubMed ID: 31005411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.
    Saulnier DM; Riehle K; Mistretta TA; Diaz MA; Mandal D; Raza S; Weidler EM; Qin X; Coarfa C; Milosavljevic A; Petrosino JF; Highlander S; Gibbs R; Lynch SV; Shulman RJ; Versalovic J
    Gastroenterology; 2011 Nov; 141(5):1782-91. PubMed ID: 21741921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
    Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
    Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 5. The microbiome of the oral mucosa in irritable bowel syndrome.
    Fourie NH; Wang D; Abey SK; Sherwin LB; Joseph PV; Rahim-Williams B; Ferguson EG; Henderson WA
    Gut Microbes; 2016 Jul; 7(4):286-301. PubMed ID: 26963804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity.
    Han L; Zhao L; Zhou Y; Yang C; Xiong T; Lu L; Deng Y; Luo W; Chen Y; Qiu Q; Shang X; Huang L; Mo Z; Huang S; Huang S; Liu Z; Yang W; Zhai L; Ning Z; Lin C; Huang T; Cheng C; Zhong LLD; Li S; Bian Z; Fang X
    ISME J; 2022 Apr; 16(4):983-996. PubMed ID: 34750528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
    Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome.
    Chumpitazi BP; Hollister EB; Oezguen N; Tsai CM; McMeans AR; Luna RA; Savidge TC; Versalovic J; Shulman RJ
    Gut Microbes; 2014; 5(2):165-75. PubMed ID: 24637601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
    Mujagic Z; Kasapi M; Jonkers DM; Garcia-Perez I; Vork L; Weerts ZZRM; Serrano-Contreras JI; Zhernakova A; Kurilshikov A; Scotcher J; Holmes E; Wijmenga C; Keszthelyi D; Nicholson JK; Posma JM; Masclee AA
    Gut Microbes; 2022; 14(1):2063016. PubMed ID: 35446234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
    Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
    Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
    BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
    Liu S; Si C; Yu Y; Zhao G; Chen L; Zhao Y; Zhang Z; Li H; Chen Y; Min L; Zhang S; Zhu S
    Front Cell Infect Microbiol; 2019; 9():178. PubMed ID: 31192167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using
    Lee JS; Kim SY; Chun YS; Chun YJ; Shin SY; Choi CH; Choi HK
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13830. PubMed ID: 32125749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
    Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
    Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.